« Previous
Next »
Titles
- Breakthrough Devices Program: guidance for industry and Food and Drug Administration staff1
- CDC has improved the nursing home reporting process for COVID-19 Data in NHSN, but challenges remain1
- Digital health technologies for remote data acquisition in clinical investigations: guidance for industry, investigators, and other stakeholders1
- FDA’s approach to overseeing online tobacco retailers needs improvement1
- Real-world data: assessing registries to support regulatory decision-making for drug and biological products : guidance for industry1
- Understanding the impacts of OS-PCORTF projects on data capacity: an interim qualitative assessment1
- Using race and ethnicity data to advance health equity: examples, promising practices, remaining challenges, and next steps1